ArticleAging clinical and experimental research2025
The trajectory of frailty index and its association with rapid decline in kidney function and the incidence of chronic kidney disease: evidence from the China health and retirement longitudinal study.
Article in Aging clinical and experimental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aims to evaluate the association between the frailty index trajectory in older adults from a longitudinal cohort and rapid decline in kidney function as well as the incidence of chronic kidney disease (CKD).
methodThis study included 4,207 participants aged 45 and above from the China Health and Retirement Longitudinal Study (CHARLS), who underwent baseline assessments in 2011-2012 and were followed up in 2013 and 2015. The study selected 31 items to construct the frailty index (FI), with the FI value positively correlated with the degree of frailty in individuals. The FI trajectories were determined using latent class trajectory modeling (LCTM). The primary outcome event was rapid decline in kidney function, with the incidence of CKD also being explored. Binary logistic regression analysis was used to examine the association between these trajectories and kidney disease. The covariates include basic demographic variables, medical history, and biochemical indicators. In addition, the dose-response relationship between cumulative frailty indicators and rapid decline in kidney function and CKD was explored within each frailty index trajectory group. We conducted subgroup and interaction analyses to explore the impact of various characteristics on this relationship. Finally, eGFRcr was used to assess kidney function and validate the consistency of previous findings.
resultsParticipants were divided into three FI trajectories: Low-stable trajectory, Moderate-stable frailty index trajectory, and Moderate-increase trajectory, which accounted for 50.68%, 37.58%, and 11.74% of the study population, respectively. Compared to participants in the Low-stable frailty index trajectory group, those in the Moderate-increase FI trajectory group had a significantly higher risk of rapid decline in kidney function, with an adjusted OR of 1.589 (95% CI, 1.013-2.442). However, the trend ORs for cumulative FI within each FI group did not show statistical significance, suggesting the reasonableness of the trajectory classification. Finally, the analysis using eGFRcr to assess kidney function was consistent with the primary results.
conclusionA higher FI trajectory is associated with an increased risk of rapid decline in kidney function. The findings underscore the critical importance of monitoring the dynamic changes in frailty among middle-aged and older adults.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.